JAMA Study Says Screening Mammograms Result in Overdiagnosis
The widespread use of screening mammography increases the probability of detecting smaller cancers without a decline in the detection of large cancers.
A collaborative study among Harvard and Dartmouth researchers has found that the widespread use of screening mammography increases the probability of detecting smaller cancers that may not be clinically relevant, without a decline in the detection of large cancers. So the increased screening does not impact mortality from breast cancers, the study concludes, and warns about overdiagnosis.
A similar conclusion was drawn by Dr Rinaa Punglia, an oncologist at the Dana-Farber Cancer Institute, during
For the present study, published in
While a positive correlation was observed between the extent of screening and breast cancer incidence, it wasn't so with breast cancer mortality. Addiitonally, increased screening raised the detection rate of smaller breast cancers (≤2 cm), but did not decline the detection of larger cancers (>2 cm). These findings, the authors conclude, indicate overdiagnosis of breast cancer. While mamography screening is necessary, the authors are of the opinion that it should be directed to patients who are at a high-risk of the disease. They also recommend watchful waiting without immediate active treatment in these individuals.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis
September 18th 2025
- Iron Dysregulation Linked to MS Progression, Review Finds
September 18th 2025
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025